← Back to Search

Oncofertility Care Intervention for Young Breast Cancer Survivors

N/A
Recruiting
Led By H. Irene Su, MD, MSCE
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Breast cancer (Stages 0-IV) diagnosis
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks after oncology visit
Awards & highlights

Study Summary

This trial will observe how well a multi-step intervention plan helps young breast cancer patients stay on track with fertility-related goals and receive the proper care.

Who is the study for?
This trial is for young women in Imperial County, California, who have been diagnosed with breast cancer (Stages 0-IV) and are not pregnant. They must speak English or Spanish and be receiving care at participating clinics.Check my eligibility
What is being tested?
The study tests a multi-component intervention aimed at improving engagement in oncofertility care that aligns with the patient's reproductive goals after surviving breast cancer.See study design
What are the potential side effects?
Since this is an intervention focused on healthcare engagement rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with breast cancer at any stage.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks after oncology visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks after oncology visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Medical record review of engagement in goal-concordant oncofertility care

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multi-component oncofertility care interventionExperimental Treatment1 Intervention
After the intervention implementation, all breast cancer patients presenting to oncology clinical visits that meet eligibility criteria will receive the multi-component oncofertility care intervention.
Group II: Usual CareActive Control1 Intervention
Prior to the intervention implementation, all breast cancer patients presenting to oncology clinical visits that meet eligibility criteria will receive usual care.

Find a Location

Who is running the clinical trial?

Pioneers Memorial Healthcare DistrictUNKNOWN
University of California, San DiegoLead Sponsor
1,117 Previous Clinical Trials
1,520,153 Total Patients Enrolled
21 Trials studying Breast Cancer
7,213 Patients Enrolled for Breast Cancer
Cancer Resource Center of the DesertUNKNOWN
1 Previous Clinical Trials
153 Total Patients Enrolled

Media Library

Multi-component oncofertility care intervention Clinical Trial Eligibility Overview. Trial Name: NCT05414812 — N/A
Breast Cancer Research Study Groups: Multi-component oncofertility care intervention, Usual Care
Breast Cancer Clinical Trial 2023: Multi-component oncofertility care intervention Highlights & Side Effects. Trial Name: NCT05414812 — N/A
Multi-component oncofertility care intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05414812 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can adolescents participate in this research project?

"According to the eligibility requirements listed, only patients aged 18-50 can take part in this particular study. However, there are 96 clinical trials available for minors and 2604 for senior citizens."

Answered by AI

Are new test subjects still being accepted for this experiment?

"From what is available on clinicaltrials.gov, it seems that this clinical trial is still looking for participants. The listing was first put up on October 15th 2021 and was updated on September 6th 2022."

Answered by AI
~4 spots leftby Apr 2024